Avanos Medical, Inc. (AVNS): Price and Financial Metrics
AVNS Price/Volume Stats
Current price | $19.13 | 52-week high | $31.31 |
Prev. close | $19.09 | 52-week low | $17.24 |
Day low | $18.94 | Volume | 273,000 |
Day high | $19.40 | Avg. volume | 321,328 |
50-day MA | $19.20 | Dividend yield | N/A |
200-day MA | $21.43 | Market Cap | 883.86M |
AVNS Stock Price Chart Interactive Chart >
AVNS POWR Grades
- Value is the dimension where AVNS ranks best; there it ranks ahead of 88.69% of US stocks.
- AVNS's strongest trending metric is Value; it's been moving down over the last 26 weeks.
- AVNS ranks lowest in Momentum; there it ranks in the 24th percentile.
AVNS Stock Summary
- Of note is the ratio of AVANOS MEDICAL INC's sales and general administrative expense to its total operating expenses; 76.19% of US stocks have a lower such ratio.
- AVNS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 20.08% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, AVANOS MEDICAL INC is reporting a growth rate of -138.95%; that's higher than merely 9.73% of US stocks.
- Stocks that are quantitatively similar to AVNS, based on their financial statements, market capitalization, and price volatility, are AQB, NEO, AOUT, KIDS, and CDXC.
- Visit AVNS's SEC page to see the company's official filings. To visit the company's web site, go to avanos.com.
AVNS Valuation Summary
- AVNS's price/sales ratio is 1.4; this is 66.67% lower than that of the median Healthcare stock.
- AVNS's price/sales ratio has moved up 0.3 over the prior 112 months.
Below are key valuation metrics over time for AVNS.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
AVNS | 2023-12-29 | 1.4 | 0.9 | -18.8 | -44.0 |
AVNS | 2023-12-28 | 1.4 | 0.9 | -19.1 | -44.5 |
AVNS | 2023-12-27 | 1.4 | 0.9 | -19.1 | -44.5 |
AVNS | 2023-12-26 | 1.4 | 0.9 | -19.1 | -44.6 |
AVNS | 2023-12-22 | 1.4 | 0.9 | -19.1 | -44.6 |
AVNS | 2023-12-21 | 1.4 | 0.9 | -19.3 | -44.9 |
AVNS Growth Metrics
- Its 3 year net income to common stockholders growth rate is now at 9.41%.
- The year over year price growth rate now stands at -25.3%.
- Its 5 year price growth rate is now at -21%.
The table below shows AVNS's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-12-31 | 820 | 90.9 | 50.5 |
2022-09-30 | 795.9 | 109.3 | 42.9 |
2022-06-30 | 777.9 | 104.1 | -7.9 |
2022-03-31 | 761.3 | 92.4 | 18.6 |
2021-12-31 | 744.6 | 87.3 | 5.2 |
2021-09-30 | 736.2 | 36.3 | -52 |
AVNS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- AVNS has a Quality Grade of C, ranking ahead of 25.13% of graded US stocks.
- AVNS's asset turnover comes in at 0.446 -- ranking 106th of 186 Medical Equipment stocks.
- NDRA, NVNO, and BLFS are the stocks whose asset turnover ratios are most correlated with AVNS.
The table below shows AVNS's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-09-30 | 0.446 | 0.484 | -0.090 |
2021-06-30 | 0.434 | 0.490 | -0.090 |
2021-03-31 | 0.416 | 0.507 | -0.081 |
2020-12-31 | 0.409 | 0.522 | -0.061 |
2020-09-30 | 0.404 | 0.548 | -0.003 |
2020-06-30 | 0.396 | 0.558 | -0.027 |
Avanos Medical, Inc. (AVNS) Company Bio
Avanos Medical, Inc. (formerly Halyard Health) is focused on preventing infection, eliminating pain and speeding recovery for healthcare providers and their patients. The company was founded in 2014 and is based in Alpharetta, Georgia.
Latest AVNS News From Around the Web
Below are the latest news stories about AVANOS MEDICAL INC that investors may wish to consider to help them evaluate AVNS as an investment opportunity.
Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. |
Avanos Medical, Inc. to Present at the Stifel 2023 Healthcare ConferenceAvanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer, will participate in an analyst-led fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, Nov. 14 at approximately 10:20 a.m. ET. |
Avanos Medical, Inc. (NYSE:AVNS) Q3 2023 Earnings Call TranscriptAvanos Medical, Inc. (NYSE:AVNS) Q3 2023 Earnings Call Transcript November 4, 2023 Operator: Good morning, and welcome to Avanos’ Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I […] |
Avanos (AVNS) Q3 Earnings Top Estimates, Margins ContractDespite strength in Avanos' (AVNS) Digestive Health segment, its overall third-quarter results reflect soft performances. |
Q3 2023 Avanos Medical Inc Earnings CallQ3 2023 Avanos Medical Inc Earnings Call |
AVNS Price Returns
1-mo | -0.31% |
3-mo | -13.67% |
6-mo | -4.83% |
1-year | -32.97% |
3-year | -58.33% |
5-year | -55.10% |
YTD | -14.71% |
2023 | -17.11% |
2022 | -21.95% |
2021 | -24.43% |
2020 | 36.14% |
2019 | -24.76% |
Continue Researching AVNS
Want to do more research on Avanos Medical Inc's stock and its price? Try the links below:Avanos Medical Inc (AVNS) Stock Price | Nasdaq
Avanos Medical Inc (AVNS) Stock Quote, History and News - Yahoo Finance
Avanos Medical Inc (AVNS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...